Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China — Stella

Home/Type 2 Diabetes Mellitus in Remission/

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes Mellitus in Remission trials

Trial locations(1 site)

China

Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu

Key details

Sponsor

Wuxi Hisky Medical Technology Co Ltd

Collaborators

Zhongda Hospital, Suzhou Municipal Hospital

Enrollment target

~2,900 participants

Started

July 2022

Primary completion

June 2023

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated October 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.